Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD: Jordan's Perspective Based on Knowledge and Attitude Determinants

被引:0
作者
Alqudah, Omar [1 ]
Alshahwan, Hamzeh Feras [2 ]
Alsamhouri, Jehad Feras [2 ]
Yamin, Saif [2 ]
Kaffaf, Ahmad [2 ]
Alassaf, Mohannad [2 ]
Alwarawrah, Zaid [3 ]
机构
[1] Univ Jordan, Jordan Univ Hosp & Sch Med, Dept Med, Div Hepatol & Gastroenterol, Amman, Jordan
[2] Univ Jordan, Sch Med, Amman, Jordan
[3] Mutah Univ, Sch Med, Al Karak, Jordan
关键词
nonalcoholic fatty liver disease; NAFLD; MASLD; hepatic steatosis; liver health; patient education; public health awareness; medical literacy; Metabolic Dysfunction-Associated Steatotic Liver Disease; PREVALENCE; OBESITY; RISK;
D O I
10.2147/RMHP.S481401
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: The most prevalent chronic liver disease in both developed and developing nations is Metabolic dysfunction-associated Steatotic Liver Disease (MASLD). The condition increases the risk of comorbidities and liver-related morbidity and mortality. The public's awareness and medical personnel's understanding are essential in creating countermeasures to stop the disease's spread; a positive attitude is essential for early screening. This study aimed to explore the knowledge and attitudes of Jordanians living in Amman toward MASLD to determine the public's awareness and medical personnel's understanding of the disease. Materials and Methods: A cross-sectional study was conducted using an online self-administered questionnaire that included 5 items for knowledge and 8 for attitude. Demographic questions were also included to further examine how demographic factors affected knowledge and attitude. Results: Among 906 responders, (63.4%) were females, and (36.6%) were males. The majority age group was 18-30 (56.2%). Only 49.5% had previous knowledge of MASLD, (44.6%) believed they were at risk of developing it. There is a statistical significance between age, gender, educational level, and having a good knowledge of MASLD and a positive attitude towards it (p<0.05). Conclusion: Generally, Jordan's population has a fair knowledge of MASLD and a positive attitude towards it. Warranting more research into the reasons behind it, and more awareness campaigns.
引用
收藏
页码:2483 / 2491
页数:9
相关论文
共 50 条
[21]   Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD) [J].
Wong, Robert J. .
METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04)
[22]   Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease [J].
Li, Yamei ;
Qi, Ping ;
Song, Si -Yuan ;
Wang, Yiping ;
Wang, Hailian ;
Cao, Peng ;
Liu, Yu 'e ;
Wang, Yi .
BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
[23]   Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance [J].
Hutchison, Alan L. ;
Tavaglione, Federica ;
Romeo, Stefano ;
Charlton, Michael .
JOURNAL OF HEPATOLOGY, 2023, 79 (06) :1524-1541
[24]   Metabolic dysfunction-associated steatotic liver disease (MASLD): Exploring systemic impacts and innovative therapies [J].
Jain, Parag ;
Jain, Akanksha ;
Deshmukh, Rohitas ;
Samal, Pradeep ;
Satapathy, Trilochan ;
Ajazuddin .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2025, 49 (06)
[25]   Update in lean metabolic dysfunction-associated steatotic liver disease [J].
Sato-Espinoza, Karina ;
Chotiprasidhi, Perapa ;
Huaman, Mariella R. ;
Diaz-Ferrer, Javier .
WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (03) :452-464
[26]   Metabolic dysfunction-associated steatotic liver disease and the cardiovascular system [J].
Manolis, Antonis A. ;
Manolis, Theodora A. ;
Vouliotis, Apostolos ;
Manolis, Antonis S. .
TRENDS IN CARDIOVASCULAR MEDICINE, 2025, 35 (04) :258-265
[27]   Management of metabolic dysfunction-associated steatotic liver disease (MASLD)-An expert consensus statement from Indian diabetologists' perspective [J].
Zargar, Abdul Hamid ;
Bhansali, Anil ;
Majumdar, Anirban ;
Maheshwari, Anuj ;
Bhattacharyya, Arpandev ;
Dasgupta, Arundhati ;
Saboo, Banshi Damodarlal ;
Sethi, Bipin Kumar ;
Sanyal, Debmalya ;
Seshadri, Krishna G. ;
Deshpande, Neeta Rohit ;
Kapoor, Nitin ;
Lakhani, Om Jitendra ;
Talwalkar, Pradeep Gopal ;
Kalra, Pramila ;
Mehrotra, Rabindera Nath ;
Sahay, Rakesh Kumar ;
Shukla, Rishi ;
Kant, Saket ;
Das, Sambit ;
Agarwal, Sanjay Chunilal ;
Phatak, Sanjeev Ratnakar ;
Shanmugasundar, G. ;
Joshi, Shashank Rameshchandra ;
Shaikh, Shehla Sajid ;
Aravind, Sosale Ramachandra ;
Goswami, Soumik ;
Ghosh, Sujoy ;
Panikar, Vijay Kumar ;
Mohan, Viswanathan .
DIABETES OBESITY & METABOLISM, 2025, 27 :3-20
[28]   Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights [J].
Aggeletopoulou, Ioanna ;
Tsounis, Efthymios P. ;
Triantos, Christos .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
[29]   Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective [J].
Eskridge, Wayne ;
Cryer, Donna R. ;
Schattenberg, Joern M. ;
Gastaldelli, Amalia ;
Malhi, Harmeet ;
Allen, Alina M. ;
Noureddin, Mazen ;
Sanyal, Arun J. .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
[30]   Epidemiology of metabolic dysfunction-associated steatotic liver disease [J].
Younossi, Zobair M. ;
Kalligeros, Markos ;
Henry, Linda .
CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31